What is the new opiate reversal drug? Unpacking Nalmefene (Opvee®) and Advancements
•
3 min read
In May 2023, the U.S. Food and Drug Administration (FDA) approved nalmefene nasal spray (Opvee®), a new opioid reversal medication for emergency use. This marks a significant development in the fight against the opioid crisis, building on decades of experience with naloxone, the standard opiate reversal drug.
